MiNK Therapeutics, Inc. Common Stock (INKT) is a publicly traded Healthcare sector company. As of May 21, 2026, INKT trades at $10.29 with a market cap of $50.02M and a P/E ratio of -3.67. INKT moved +4.15% today. Year to date, INKT is -11.11%; over the trailing twelve months it is +48.60%. Its 52-week range spans $4.56 to $76.00. Analyst consensus is buy with an average price target of $35.00. Rallies surfaces INKT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
MiNK Therapeutics, Inc. Common Stock (INKT) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. INKT moved +4.15% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $10.29 |
| Market Cap | $50.02M |
| P/E Ratio | -3.67 |
| EPS | $-2.93 |
| Dividend Yield | 0.00% |
| 52-Week High | $76.00 |
| 52-Week Low | $4.56 |
| Volume | 9 |
| Avg Volume | 0 |
| Revenue (TTM) | $180.25K |
| Net Income | $-12.49M |
| Gross Margin | 0.00% |
1 analysts cover INKT: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $35.00.